BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Prognosis
111 results:

  • 1. Case report: Pathological complete response induced by immunochemotherapy in a case of Pulmonary Sarcomatoid Carcinoma staged IIIA-N2.
    Guo Y; Liu X; Tang H; Qiu Z; Ma F; Hu A; Liu C; Wang Y
    Front Immunol; 2024; 15():1374270. PubMed ID: 38650938
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Radiotherapy combined with anti-PD-1 and TKI for primary cardiac angiosarcoma considering the joint assessment of TLSs and pd-l1: a case report.
    Deng S; Yang X; He L; Zhang Q; Zhao C; Meng H
    J Cardiothorac Surg; 2024 Apr; 19(1):194. PubMed ID: 38594687
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.
    Liao Z; Teng J; Li T; Liu H; Li T; Zhang C; Xing R; Teng S; Yang Y; Zhao J; Xiao W; Zhang G; Li MJ; Yao W; Yang J
    Front Immunol; 2024; 15():1292325. PubMed ID: 38585276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary pulmonary histiocytic sarcoma with high pd-l1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
    Lin Y; Cao Q; Hong A; Liang X
    Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment
    Higgins TA; Patton DJ; Shimko-Lofano IM; Eller TL; Molinari R; Sandey M; Ismail A; Smith BF; Agarwal P
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391964
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment and prognostic implications of strong pd-l1 expression in primary hepatic sarcomatoid carcinoma.
    Radhakrishnan S; Martin CA; Vij M; Subbiah K; Raju LP; Gowrishankar G; Veldore VH; Kaliamoorthy I; Rammohan A; Rela M
    Immunotherapy; 2024 Apr; 16(6):371-379. PubMed ID: 38362631
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma.
    Tang S; Wang Y; Luo R; Fang R; Liu Y; Xiang H; Ran P; Tong Y; Sun M; Tan S; Huang W; Huang J; Lv J; Xu N; Yao Z; Zhang Q; Xu Z; Yue X; Yu Z; Akesu S; Ding Y; Xu C; Lu W; Zhou Y; Hou Y; Ding C
    Nat Commun; 2024 Feb; 15(1):1381. PubMed ID: 38360860
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
    Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 10. PROGNOSTIC IMPLICATIONS OF pd-l1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
    Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
    Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
    Zhou Z; Lin Z; Wang M; Wang L; Ji Y; Yang J; Yang Y; Zhu G; Liu T
    Eur J Med Res; 2024 Jan; 29(1):12. PubMed ID: 38173048
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation.
    Luk SJ; Schoppmeyer R; Ijsselsteijn ME; Somarakis A; Acem I; Remst DFG; Cox DT; van Bergen CAM; Briaire-de Bruijn I; Grönloh MLB; van der Meer WJ; Hawinkels LJAC; Koning RI; Bos E; Bovée JVMG; de Miranda NFCC; Szuhai K; van Buul JD; Falkenburg JHF; Heemskerk MHM
    Cancer Immunol Res; 2023 Nov; 11(11):1480-1492. PubMed ID: 37695550
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.
    Stevenson VB; Gudenschwager-Basso EK; Klahn S; LeRoith T; Huckle WR
    Vet Comp Oncol; 2023 Dec; 21(4):709-716. PubMed ID: 37680007
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
    Chen AP; Sharon E; O'Sullivan-Coyne G; Moore N; Foster JC; Hu JS; Van Tine BA; Conley AP; Read WL; Riedel RF; Burgess MA; Glod J; Davis EJ; Merriam P; Naqash AR; Fino KK; Miller BL; Wilsker DF; Begum A; Ferry-Galow KV; Deshpande HA; Schwartz GK; Ladle BH; Okuno SH; Beck JC; Chen JL; Takebe N; Fogli LK; Rosenberger CL; Parchment RE; Doroshow JH
    N Engl J Med; 2023 Sep; 389(10):911-921. PubMed ID: 37672694
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
    Wang J; Elghawy O; Kurpiel B; Kaur V
    Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
    Wu Y; Lin Z; Tang X; Tong Z; Ji Y; Xu Y; Zhou Z; Yang J; Li Z; Liu T
    Front Immunol; 2023; 14():1182030. PubMed ID: 37388742
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
    Wang H; Li J; Li X
    Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.
    Sun X; Wang X; Zhou J; Xu Y; Zhang H; Xu M; Shen J; Shi X; Song W; Li J
    Medicine (Baltimore); 2023 May; 102(21):e33858. PubMed ID: 37233406
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.